ChronicleBio

[Dolphin]

Solve ME shared this on their social media:

Congratulations to our partner ChronicleBio on their big launch today!
—-

We’re building the world’s most advanced, AI-powered data platform for neuroimmune disorders like POTS, ME/CFS, Long COVID, and other complex chronic conditions that have been overlooked for far too long.

Millions of patients are living without answers or effective treatments—not because these conditions aren’t real or serious, but because the tools to understand them haven’t existed. We’re here to change that.

ChronicleBio brings together cutting-edge technology, precision biobanking, and patient-centered research to drive discovery where it’s needed most.

Our mission:
Generate rich, multi-omic datasets
Power AI models for real-world discovery
Unlock new diagnostics, treatments, and clinical trial opportunities

We’re honored to partner with patients, clinicians, and researchers worldwide. This is just the beginning.

https://chroniclebio.com/news/mergi...llions-living-with-complex-chronic-conditions

 

[Utsikt]

ChronicleBio is uniquely led by a founding team that unites elite tech, healthcare, and life sciences:

• Fidji Simo (Co-founder), current CEO of Instacart and the incoming CEO of OpenAI’s applications division, brings deep expertise in consumer-scale technology, product innovation, and health systems transformation.
• Rohit Gupta (Co-founder & CEO), a biobanking and precision medicine leader who previously oversaw centers at Stanford and UCSF, is the leading scientific and strategic force behind ChronicleBio.
• Rishi Reddy (Co-founder & Executive Chairman), of Tarsadia Investments, brings an entrepreneurial and venture-backed perspective and a track record in health and life sciences investing.

ChronicleBio’s founding vision isn’t just ambitious. It’s personal. Both Simo and Reddy have been diagnosed with at least one of the very conditions the company is focused on researching. Gupta’s family also suffers from neuroimmune disorders.

ChronicleBio’s approach includes:

• A global biobank platform collecting and connecting data on neuroimmune illnesses
• A proprietary, AI-ready data engine designed to integrate multi-omic, clinical, and real-world evidence
• Strategic partnerships with clinics, research consortia, and biotech sponsors looking to unlock hard-to-crack therapeutic areas
• A decentralized clinical trial network accelerating drug development through real-world access to patients and clinicians

Can’t say I fully understand what exactly they are going to do, but it seems to at least be headed by people that might be able to make it happen.